Clinical Trial Update: Repurposing Chlorpromazine in the Treatment of Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring repurposing of chlorpromazine for glioblastoma, including MGMT-unmethylated subtype.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Mgmt-unmethylated Glioblastoma

Drugs mentioned

• Chlorpromazine (chlorpromazine)

Snippet

Sponsor: Marco G Paggi, MD, PhD | Conditions: Glioblastoma Multiforme, MGMT-Unmethylated Glioblastoma | Phase 2 | Status: UNKNOWN